An FDA Bioresearch Monitoring (BIMO) inspection of a Polish clinical investigator resulted in a Warning Letter concerned with improper record keeping. The letter alleged the investigator – Konrad Rejdak, M.D. in Lublin, Poland – failed to: prepare and maintain adequate and accurate case histories that recorded all observations and other data pertinent to the investigation ... Read More